# FDA 483 - UCB Pharma S.A. - February 04, 2022

Source: https://www.globalkeysolutions.net/records/483/ucb-pharma-sa/4d10a705-f62a-4e4d-a1a3-bc75539da471

> FDA 483 for UCB Pharma S.A. on February 04, 2022. Product: Devices. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: UCB Pharma S.A.
- Inspection Date: 2022-02-04
- Product Type: Devices
- Office Name: Center for Devices and Radiological Health

## Related Documents

- [EIR - 2022-02-04](https://www.globalkeysolutions.net/records/eir/ucb-pharma-sa/c0412e1a-bd81-4e61-8d2c-6bc873ddb1ac)
- [EIR - 2023-04-21](https://www.globalkeysolutions.net/records/eir/ucb-pharma-sa/0a4d5150-1f3d-4902-a9e3-98e6c80b367f)

## Related Officers

- [Investigator](https://www.globalkeysolutions.net/people/roger-f-zabinski/87e05838-f8b5-489a-8db7-6669e68a2c2e)
- [Senior Regulatory Specialist](https://www.globalkeysolutions.net/people/wayne-e-seifert/e92e1f10-c61e-4b08-9156-25907e5e2942)

Company: https://www.globalkeysolutions.net/companies/ucb-pharma-sa/6a03badf-6619-4125-b598-85ceebcc8c50

Office: https://www.globalkeysolutions.net/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7